Establishment Labs Holdings (ESTA) Consolidated Net Income (2017 - 2026)

Establishment Labs Holdings' (ESTA) quarterly Consolidated Net Income came in at -$13.4 million in Q1 2026, up 35.38% year-on-year from -$9.9 million in Q1 2025, and down 411.74% quarter-over-quarter from -$2.6 million in Q4 2025.

Establishment Labs Holdings (ESTA) Consolidated Net Income (2017 - 2026) Analysis & Trends

Establishment Labs Holdings' Consolidated Net Income history runs 10 years deep, the most recent figure standing at -$13.4 million for Q1 2026.

  • On a quarterly basis, Consolidated Net Income rose 35.38% year-over-year to -$13.4 million in Q1 2026; TTM through Mar 2026 was -$43.7 million, a 50.92% increase from a year earlier, with the FY2025 full-year figure at -$51.1 million, up 39.64% from the prior year.
  • Consolidated Net Income slipped to -$13.4 million in Q1 2026 per ESTA's latest filing, from -$2.6 million in the prior quarter.
  • Across five years, Consolidated Net Income topped out at -$2.6 million in Q4 2025 and bottomed at -$37.1 million in Q2 2022.
  • The 5-year median for Consolidated Net Income is -$16.7 million (2024), against an average of -$17.8 million.
  • Across the five-year window, Consolidated Net Income sank 597.22% in 2022 and soared 92.43% in 2025, its largest moves.
  • Year by year, Consolidated Net Income stood at -$13.6 million in 2022, then plunged by 51.47% to -$20.5 million in 2023, then sank by 68.1% to -$34.5 million in 2024, then surged by 92.43% to -$2.6 million in 2025, then tumbled by 411.74% to -$13.4 million in 2026.
  • Per Business Quant, the three latest ESTA Consolidated Net Income figures stand at -$13.4 million (Q1 2026), -$2.6 million (Q4 2025), and -$11.1 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Abbott Laboratories 183.48 Bn 176.19 Bn 6.27 Bn 1.08 Bn
2 Stryker 129.11 Bn 126.23 Bn 3.81 Bn 745.00 Mn
3 Medtronic 108.35 Bn 99.13 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 68.68 Bn 67.22 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 48.35 Bn 44.67 Bn 1.29 Bn -
6 Dexcom 28.38 Bn 27.26 Bn 750.30 Mn 199.50 Mn
7 GE HealthCare Technologies 28.04 Bn 25.76 Bn 1.98 Bn 411.00 Mn
8 Smith & Nephew 26.92 Bn 26.35 Bn - -
9 Koninklijke Philips 24.06 Bn 20.93 Bn 2.07 Bn 273.95 Mn
10 Establishment Labs Holdings 2.75 Bn 2.68 Bn 42.34 Mn -13.38 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -13.38 Mn
Dec 31, 2025 -2.62 Mn
Sep 30, 2025 -11.15 Mn
Jun 30, 2025 -16.59 Mn
Mar 31, 2025 -20.71 Mn
Dec 31, 2024 -34.53 Mn
Sep 30, 2024 -16.68 Mn
Jun 30, 2024 -17.18 Mn
Mar 31, 2024 -16.20 Mn
Dec 31, 2023 -20.54 Mn
Sep 30, 2023 -29.27 Mn
Jun 30, 2023 -16.75 Mn
Mar 31, 2023 -11.94 Mn
Dec 31, 2022 -13.56 Mn
Sep 30, 2022 -18.61 Mn
Jun 30, 2022 -37.11 Mn
Mar 31, 2022 -5.93 Mn
Dec 31, 2021 -14.19 Mn
Sep 30, 2021 -14.68 Mn
Jun 30, 2021 -5.32 Mn